Global Healthcare Bioconvergence Market Size, Share & Industry Trends Analysis Report By Application (Drug Discovery, Precision Medicine, Regenerative Medicine, Diagnostic & Biological Sensors, Bioelectronics, Nanorobotics for Drug Delivery, Engineered Living Materials, and Optogenetics), By Regional Outlook and Forecast, 2022 - 2028

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Healthcare Bioconvergence Market, by Application
1.4.2 Global Healthcare Bioconvergence Market, by Geography
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Global Healthcare Bioconvergence Market by Application
3.1 Global Drug Discovery Market by Region
3.2 Global Precision Medicine Market by Region
3.3 Global Regenerative Medicine Market by Region
3.4 Global Diagnostic & Biological Sensors Market by Region
3.5 Global Bioelectronics Market by Region
3.6 Global Nanorobotics for Drug Delivery Market by Region
3.7 Global Engineered Living Materials Market by Region
3.8 Global Optogenetics Market by Region

Chapter 4. Global Healthcare Bioconvergence Market by Region
4.1 North America Healthcare Bioconvergence Market
4.1.1 North America Healthcare Bioconvergence Market by Application
4.1.1.1 North America Drug Discovery Market by Country
4.1.1.2 North America Precision Medicine Market by Country
4.1.1.3 North America Regenerative Medicine Market by Country
4.1.1.4 North America Diagnostic & Biological Sensors Market by Country
4.1.1.5 North America Bioelectronics Market by Country
4.1.1.6 North America Nanorobotics for Drug Delivery Market by Country
4.1.1.7 North America Engineered Living Materials Market by Country
4.1.1.8 North America Optogenetics Market by Country
4.1.2 North America Healthcare Bioconvergence Market by Country
4.1.2.1 US Healthcare Bioconvergence Market
4.1.2.1.1 US Healthcare Bioconvergence Market by Application
4.1.2.2 Canada Healthcare Bioconvergence Market
4.1.2.2.1 Canada Healthcare Bioconvergence Market by Application
4.1.2.3 Mexico Healthcare Bioconvergence Market
4.1.2.3.1 Mexico Healthcare Bioconvergence Market by Application
4.1.2.4 Rest of North America Healthcare Bioconvergence Market
4.1.2.4.1 Rest of North America Healthcare Bioconvergence Market by Application
4.2 Europe Healthcare Bioconvergence Market
4.2.1 Europe Healthcare Bioconvergence Market by Application
4.2.1.1 Europe Drug Discovery Market by Country
4.2.1.2 Europe Precision Medicine Market by Country
4.2.1.3 Europe Regenerative Medicine Market by Country
4.2.1.4 Europe Diagnostic & Biological Sensors Market by Country
4.2.1.5 Europe Bioelectronics Market by Country
4.2.1.6 Europe Nanorobotics for Drug Delivery Market by Country
4.2.1.7 Europe Engineered Living Materials Market by Country
4.2.1.8 Europe Optogenetics Market by Country
4.2.2 Europe Healthcare Bioconvergence Market by Country
4.2.2.1 Germany Healthcare Bioconvergence Market
4.2.2.1.1 Germany Healthcare Bioconvergence Market by Application
4.2.2.2 UK Healthcare Bioconvergence Market
4.2.2.2.1 UK Healthcare Bioconvergence Market by Application
4.2.2.3 France Healthcare Bioconvergence Market
4.2.2.3.1 France Healthcare Bioconvergence Market by Application
4.2.2.4 Russia Healthcare Bioconvergence Market
4.2.2.4.1 Russia Healthcare Bioconvergence Market by Application
4.2.2.5 Spain Healthcare Bioconvergence Market
4.2.2.5.1 Spain Healthcare Bioconvergence Market by Application
4.2.2.6 Italy Healthcare Bioconvergence Market
4.2.2.6.1 Italy Healthcare Bioconvergence Market by Application
4.2.2.7 Rest of Europe Healthcare Bioconvergence Market
4.2.2.7.1 Rest of Europe Healthcare Bioconvergence Market by Application
4.3 Asia Pacific Healthcare Bioconvergence Market
4.3.1 Asia Pacific Healthcare Bioconvergence Market by Application
4.3.1.1 Asia Pacific Drug Discovery Market by Country
4.3.1.2 Asia Pacific Precision Medicine Market by Country
4.3.1.3 Asia Pacific Regenerative Medicine Market by Country
4.3.1.4 Asia Pacific Diagnostic & Biological Sensors Market by Country
4.3.1.5 Asia Pacific Bioelectronics Market by Country
4.3.1.6 Asia Pacific Nanorobotics for Drug Delivery Market by Country
4.3.2 Asia Pacific Engineered Living Materials Market by Country
4.3.2.1 Asia Pacific Optogenetics Market by Country
4.3.3 Asia Pacific Healthcare Bioconvergence Market by Country
4.3.3.1 China Healthcare Bioconvergence Market
4.3.3.1.1 China Healthcare Bioconvergence Market by Application
4.3.3.2 Japan Healthcare Bioconvergence Market
4.3.3.2.1 Japan Healthcare Bioconvergence Market by Application
4.3.3.3 India Healthcare Bioconvergence Market
4.3.3.3.1 India Healthcare Bioconvergence Market by Application
4.3.3.4 South Korea Healthcare Bioconvergence Market
4.3.3.4.1 South Korea Healthcare Bioconvergence Market by Application
4.3.3.5 Singapore Healthcare Bioconvergence Market
4.3.3.5.1 Singapore Healthcare Bioconvergence Market by Application
4.3.3.6 Malaysia Healthcare Bioconvergence Market
4.3.3.6.1 Malaysia Healthcare Bioconvergence Market by Application
4.3.3.7 Rest of Asia Pacific Healthcare Bioconvergence Market
4.3.3.7.1 Rest of Asia Pacific Healthcare Bioconvergence Market by Application
4.4 LAMEA Healthcare Bioconvergence Market
4.4.1 LAMEA Healthcare Bioconvergence Market by Application
4.4.1.1 LAMEA Drug Discovery Market by Country
4.4.1.2 LAMEA Precision Medicine Market by Country
4.4.1.3 LAMEA Regenerative Medicine Market by Country
4.4.1.4 LAMEA Diagnostic & Biological Sensors Market by Country
4.4.1.5 LAMEA Bioelectronics Market by Country
4.4.1.6 LAMEA Nanorobotics for Drug Delivery Market by Country
4.4.1.7 LAMEA Engineered Living Materials Market by Country
4.4.1.8 LAMEA Optogenetics Market by Country
4.4.2 LAMEA Healthcare Bioconvergence Market by Country
4.4.2.1 Brazil Healthcare Bioconvergence Market
4.4.2.1.1 Brazil Healthcare Bioconvergence Market by Application
4.4.2.2 Argentina Healthcare Bioconvergence Market
4.4.2.2.1 Argentina Healthcare Bioconvergence Market by Application
4.4.2.3 UAE Healthcare Bioconvergence Market
4.4.2.3.1 UAE Healthcare Bioconvergence Market by Application
4.4.2.4 Saudi Arabia Healthcare Bioconvergence Market
4.4.2.4.1 Saudi Arabia Healthcare Bioconvergence Market by Application
4.4.2.5 South Africa Healthcare Bioconvergence Market
4.4.2.5.1 South Africa Healthcare Bioconvergence Market by Application
4.4.2.6 Nigeria Healthcare Bioconvergence Market
4.4.2.6.1 Nigeria Healthcare Bioconvergence Market by Application
4.4.2.7 Rest of LAMEA Healthcare Bioconvergence Market
4.4.2.7.1 Rest of LAMEA Healthcare Bioconvergence Market by Application

Chapter 5. Company Profiles
5.1 BiomX, Inc.
5.1.1 Company Overview
5.1.2 Research & Development Expenses
5.2 Galvani Bioelectronics, Ltd. (GlaxoSmithKline plc and Verily Life Sciences)
5.2.1 Company Overview
5.2.2 Financial Analysis
5.2.3 Segmental and Regional Analysis
5.2.4 Research & Development Expenses
5.3 BICO Group AB (publ)
5.3.1 Company Overview
5.3.2 Financial Analysis
5.3.3 Segmental and Regional Analysis
5.3.4 Recent strategies and developments:
5.3.4.1 Partnerships, Collaborations, and Agreements:
5.3.4.2 Acquisition and Mergers:
5.4 Ginkgo Bioworks Holdings, Inc.
5.4.1 Company Overview
5.4.2 Financial Analysis
5.4.3 Research & Development Expenses
5.4.4 Recent strategies and developments:
5.4.4.1 Partnerships, Collaborations, and Agreements:
5.5 Singota Solutions
5.5.1 Company Overview
5.6 Anima Biotech Inc.
5.6.1 Company Overview
5.7 Setpoint Medical Corporation
5.7.1 Company Overview